Literature DB >> 28252453

An Evidence Synthesis Approach to Estimating the Proportion of Influenza Among Influenza-like Illness Patients.

Scott A McDonald1, Michiel van Boven, Jacco Wallinga.   

Abstract

BACKGROUND: Estimation of the national-level incidence of seasonal influenza is notoriously challenging. Surveillance of influenza-like illness is carried out in many countries using a variety of data sources, and several methods have been developed to estimate influenza incidence. Our aim was to obtain maximally informed estimates of the proportion of influenza-like illness that is true influenza using all available data.
METHODS: We combined data on weekly general practice sentinel surveillance consultation rates for influenza-like illness, virologic testing of sampled patients with influenza-like illness, and positive laboratory tests for influenza and other pathogens, applying Bayesian evidence synthesis to estimate the positive predictive value (PPV) of influenza-like illness as a test for influenza virus infection. We estimated the weekly number of influenza-like illness consultations attributable to influenza for nine influenza seasons, and for four age groups.
RESULTS: The estimated PPV for influenza in influenza-like illness patients was highest in the weeks surrounding seasonal peaks in influenza-like illness rates, dropping to near zero in between-peak periods. Overall, 14.1% (95% credible interval [CrI]: 13.5%, 14.8%) of influenza-like illness consultations were attributed to influenza infection; the estimated PPV was 50% (95% CrI: 48%, 53%) for the peak weeks and 5.8% during the summer periods.
CONCLUSIONS: The model quantifies the correspondence between influenza-like illness consultations and influenza at a weekly granularity. Even during peak periods, a substantial proportion of influenza-like illness-61%-was not attributed to influenza. The much lower proportion of influenza outside the peak periods reflects the greater circulation of other respiratory pathogens relative to influenza.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28252453     DOI: 10.1097/EDE.0000000000000646

Source DB:  PubMed          Journal:  Epidemiology        ISSN: 1044-3983            Impact factor:   4.822


  6 in total

1.  Excess Deaths Attributable to Influenza-Like Illness in the ESRD Population.

Authors:  David T Gilbertson; Kenneth J Rothman; Glenn M Chertow; Brian D Bradbury; M Alan Brookhart; Jiannong Liu; Wolfgang C Winkelmayer; Til Stürmer; Keri L Monda; Charles A Herzog; Akhtar Ashfaq; Allan J Collins; James B Wetmore
Journal:  J Am Soc Nephrol       Date:  2019-01-24       Impact factor: 10.121

2.  Seasonal Activity of Influenza in Iran: Application of Influenza-like Illness Data from Sentinel Sites of Healthcare Centers during 2010 to 2015.

Authors:  Seyedhadi Hosseini; Manoochehr Karami; Maryam Farhadian; Younes Mohammadi
Journal:  J Epidemiol Glob Health       Date:  2018-12

3.  Influenza-like illness in Australia: A comparison of general practice surveillance system with electronic medical records.

Authors:  Carla De Oliveira Bernardo; David Alejandro González-Chica; Monique Chilver; Nigel Stocks
Journal:  Influenza Other Respir Viruses       Date:  2020-06-24       Impact factor: 4.380

4.  Characterizing the transmission patterns of seasonal influenza in Italy: lessons from the last decade.

Authors:  Caterina Rizzo; Stefano Merler; Marco Ajelli; Filippo Trentini; Elena Pariani; Antonino Bella; Giulio Diurno; Lucia Crottogini
Journal:  BMC Public Health       Date:  2022-01-06       Impact factor: 3.295

5.  North to south gradient and local waves of influenza in Chile.

Authors:  Christian Garcia-Calavaro; Lee H Harrison; Darya Pokutnaya; Christina F Mair; Maria M Brooks; Wilbert van Panhuis
Journal:  Sci Rep       Date:  2022-02-14       Impact factor: 4.379

6.  Temporal cross-correlation between influenza-like illnesses and invasive pneumococcal disease in The Netherlands.

Authors:  Wilke Hendriks; Hendriek Boshuizen; Arnold Dekkers; Mirjam Knol; Ge A Donker; Arie van der Ende; Hester Korthals Altes
Journal:  Influenza Other Respir Viruses       Date:  2017-01-03       Impact factor: 4.380

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.